Theophylline Tablet, Extended Release
Product Images NDC 69315-227

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 69315-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalsrtucture (Chemicalsrtucture)

Chemical structure of the active ingredient Theophylline. The image includes the molecular formula C7H8N4O2 and molecular weight 180.17.*

FDA Label Image

Containerlabel300mg100cc (Containerlabel300mg100cc)

Theophylline Extended-Release Tablets 300 mg label from Leading Pharma, LLC. The label indicates the product contains 300 mg anhydrous theophylline per tablet, with 100 tablets per package. It includes warnings about storage, packaging, dosing, and child safety. The manufacturer address and a barcode are also visible.*

FDA Label Image

Containerlabel450mg100cc (Containerlabel450mg100cc)

Label for Theophylline Extended-Release Tablets 450 mg by Leading Pharma, LLC. The label indicates 100 tablets in the package, for prescription use only. It includes storage instructions, dispensing requirements, and manufacturer contact details. The packaging also features a barcode and NDC number 69315-227-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.